LTFS
IMDZ

Ladenburg Thalmann Financial Services’s Immune Design Corp. IMDZ Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-330
Closed -$1K – 5598
2018
Q2 		$1K Hold
330
– – ﹤0.01% 5080
2018
Q1 		$1K Hold
330
– – ﹤0.01% 5080
2017
Q4 		$1K Hold
330
– – ﹤0.01% 5003
2017
Q3 		$3K Hold
330
– – ﹤0.01% 4634
2017
Q2 		$3K Hold
330
– – ﹤0.01% 4553
2017
Q1 		$2K Buy
+330
New +$1.91K ﹤0.01% 4654

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IMDZ Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 330 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in IMDZ in Q1 2017 and held it in 6 quarters. The position peaked at $3K in Q3 2017. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 330 Immune Design Corp. shares in Q3 2018, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Immune Design Corp. in Q1 2017 and held it in 6 quarters.
  • Ladenburg Thalmann Financial Services's Immune Design Corp. position peaked at $3K in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.